WASHINGTON — A bipartisan group of four senators on Monday introduced a bill they say would better align Alzheimer’s treatment and prevention strategies with public health approaches for other chronic health conditions, allowing the Centers for Disease Control and Prevention to “create a modern infrastructure for the prevention, treatment, and care of Alzheimer’s and related dementias.”
The legislation, authored by Sens. Susan Collins (R-Maine), Catherine Cortez Masto (D-Nev.), Shelley Moore Capito (R-W.Va.), and Tim Kaine (D-Va.), focuses on improving early detection mechanisms, local health program coordination, and data-gathering operations.
The Alzheimer’s Association, an advocacy group backing the legislation, estimates that nearly one-half of Americans with Alzheimer’s currently go undiagnosed, and that the disease’s prevalence among multiple minority groups is at least 50 percent higher than in white Americans.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect